Office-Based Asthma Screening Intervention

This study has been completed.
Sponsor:
Collaborators:
Halcyon Hill Foundation
Robert Wood Johnson Foundation
Information provided by:
University of Rochester
ClinicalTrials.gov Identifier:
NCT00156468
First received: September 8, 2005
Last updated: May 11, 2011
Last verified: May 2011

September 8, 2005
May 11, 2011
October 2003
Not Provided
"Preventive Medication Actions (PMA)" taken by the provider at the time of the child's visit. A "PMA" is defined as a new medication prescription or change in medication dose.
Same as current
Complete list of historical versions of study NCT00156468 on ClinicalTrials.gov Archive Site
Alternate actions taken by the provider such as: discussion of environmental controls, medication refills, etc.
Same as current
Not Provided
Not Provided
 
Office-Based Asthma Screening Intervention
Office-Based Asthma Screening Intervention

In prior work, we found that even children who have been seen by their physicians within the prior six months were frequently misclassified as having mild rather than persistent asthma. This study evaluations whether systematic office-based screening assists primary care physicians in identifying children with significant asthma and improves preventive care for asthma. We hypothesize that standardized screening in the office setting will improve the physician's ability to (a) identify children with significant asthma and (b) prescribe appropriate preventive medications.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind
Primary Purpose: Prevention
Asthma
Behavioral: Provider Prompt
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
365
September 2005
Not Provided

Inclusion Criteria:

  • Children ages 2-12
  • Children arriving for an office visit in two Rochester, NY pediatric clinics
  • Children with a prior diagnosis of asthma AND an exacerbation of symptoms within the previous 2 years

Exclusion Criteria:

  • Children arriving at the office visit with an adult that is not their parent or guardian
  • Children arriving at the office visit with a parent or guardian that does not speak English
  • Children with other medical conditions making the assessment of asthma severity difficult (cystic fibrosis, heart conditions, etc.)
Both
2 Years to 12 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00156468
10035
Not Provided
Not Provided
University of Rochester
  • Halcyon Hill Foundation
  • Robert Wood Johnson Foundation
Principal Investigator: Jill S Halterman, MD, MPH University of Rochester
University of Rochester
May 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP